FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005338735> ?p ?o ?g. }

• W2005338735 endingPage "46" @default.
• W2005338735 startingPage "37" @default.
• W2005338735 abstract "1. Human formyl peptide-receptor-like-1 (FPRL-1) is a promiscuous G protein-coupled receptor (GPCR), and belongs to a chemoattractant receptor family protein. This receptor has been reported to interact with various host-derived peptides and lipids involved in inflammatory responses. We described here, a novel role for FPRL-1 as a high-affinity beta-chemokine receptor for an N-terminally truncated form of the CKbeta8 (CCL23/MPIF-1) splice variant CKbeta8-1 (22-137 aa). 2. RT-PCR analysis of mRNA derived from human tissues and cells revealed a predominant expression of FPRL-1 in inflammatory cells, particularly in neutrophils. 3. Intracellular calcium mobilisation assay, used as screening tool, in recombinant Chinese hamster ovary (CHO-K1) and human embryonic kidney (HEK293s) cells coexpressing FPRL-1 and Galpha(16), demonstrated FPRL-1 is a functional high-affinity receptor for CKbeta8-1 (46-137 aa, sCKbeta8-1), with pEC(50) values of 9.13 and 8.85, respectively. 4. The FPRL-1 activation in CHO-K1 cells is mediated by Galpha(i)/Galpha(o) proteins, as assessed by pertussis toxin sensitivity and inhibition of forskolin-induced cyclic AMP accumulation. 5. Binding experiments were performed with a radio-iodinated synthetic peptide, [(125-)I]-WKYMVm, a known potent FPRL-1 agonist. CHO-K1 cell membranes expressing FPRL-1 bound [(125-)I]-WKYMVm with a K(d) value of 9.34. Many known FPRL-1 agonists were tested and sCKbeta8-1 was the most effective nonsynthetic ligand in displacing the radiolabelled agonist, with a pIC(50) of 7.97. 6. The functional significance of sCKbeta8-1 interaction with FPRL-1 was further demonstrated by the activation of polymorphonuclear leukocytes (PMNs) calcium mobilisation and chemotaxis. These interactions were shown to be via FPRL-1 by specific blockade of PMNs activation in the presence of an FPRL-1 antibody." @default.
• W2005338735 created "2016-06-24" @default.
• W2005338735 creator A5006248963 @default.
• W2005338735 creator A5017131080 @default.
• W2005338735 creator A5023235750 @default.
• W2005338735 creator A5030399634 @default.
• W2005338735 creator A5030922502 @default.
• W2005338735 creator A5037516027 @default.
• W2005338735 creator A5038864833 @default.
• W2005338735 creator A5066337213 @default.
• W2005338735 creator A5070697368 @default.
• W2005338735 creator A5073208001 @default.
• W2005338735 creator A5003736842 @default.
• W2005338735 date "2004-01-01" @default.
• W2005338735 modified "2023-10-14" @default.
• W2005338735 title "A truncated form of CK<i>β</i>8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor" @default.
• W2005338735 cites W1498425904 @default.
• W2005338735 cites W1506412310 @default.
• W2005338735 cites W1532214508 @default.
• W2005338735 cites W1535189536 @default.
• W2005338735 cites W1539698363 @default.
• W2005338735 cites W1579647545 @default.
• W2005338735 cites W1631597983 @default.
• W2005338735 cites W1767991896 @default.
• W2005338735 cites W1979751791 @default.
• W2005338735 cites W1991786670 @default.
• W2005338735 cites W1994417030 @default.
• W2005338735 cites W1998279017 @default.
• W2005338735 cites W2001402428 @default.
• W2005338735 cites W2021905899 @default.
• W2005338735 cites W2031158167 @default.
• W2005338735 cites W2037697142 @default.
• W2005338735 cites W2044712218 @default.
• W2005338735 cites W2045608528 @default.
• W2005338735 cites W2049593316 @default.
• W2005338735 cites W2053146787 @default.
• W2005338735 cites W2066959564 @default.
• W2005338735 cites W2069239888 @default.
• W2005338735 cites W2079041972 @default.
• W2005338735 cites W2092974032 @default.
• W2005338735 cites W2093259734 @default.
• W2005338735 cites W2098965240 @default.
• W2005338735 cites W2103302057 @default.
• W2005338735 cites W2109014958 @default.
• W2005338735 cites W2114546020 @default.
• W2005338735 cites W2139357620 @default.
• W2005338735 cites W2149138253 @default.
• W2005338735 cites W2159543436 @default.
• W2005338735 cites W2165724413 @default.
• W2005338735 cites W2253106292 @default.
• W2005338735 cites W4313343507 @default.
• W2005338735 doi "https://doi.org/10.1038/sj.bjp.0705592" @default.
• W2005338735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1574175" @default.
• W2005338735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14662730" @default.
• W2005338735 hasPublicationYear "2004" @default.
• W2005338735 type Work @default.
• W2005338735 sameAs 2005338735 @default.
• W2005338735 citedByCount "47" @default.
• W2005338735 countsByYear W20053387352012 @default.
• W2005338735 countsByYear W20053387352013 @default.
• W2005338735 countsByYear W20053387352014 @default.
• W2005338735 countsByYear W20053387352016 @default.
• W2005338735 countsByYear W20053387352018 @default.
• W2005338735 countsByYear W20053387352019 @default.
• W2005338735 countsByYear W20053387352020 @default.
• W2005338735 crossrefType "journal-article" @default.
• W2005338735 hasAuthorship W2005338735A5003736842 @default.
• W2005338735 hasAuthorship W2005338735A5006248963 @default.
• W2005338735 hasAuthorship W2005338735A5017131080 @default.
• W2005338735 hasAuthorship W2005338735A5023235750 @default.
• W2005338735 hasAuthorship W2005338735A5030399634 @default.
• W2005338735 hasAuthorship W2005338735A5030922502 @default.
• W2005338735 hasAuthorship W2005338735A5037516027 @default.
• W2005338735 hasAuthorship W2005338735A5038864833 @default.
• W2005338735 hasAuthorship W2005338735A5066337213 @default.
• W2005338735 hasAuthorship W2005338735A5070697368 @default.
• W2005338735 hasAuthorship W2005338735A5073208001 @default.
• W2005338735 hasBestOaLocation W20053387352 @default.
• W2005338735 hasConcept C125268873 @default.
• W2005338735 hasConcept C135285700 @default.
• W2005338735 hasConcept C153911025 @default.
• W2005338735 hasConcept C170493617 @default.
• W2005338735 hasConcept C174510640 @default.
• W2005338735 hasConcept C175656101 @default.
• W2005338735 hasConcept C17971392 @default.
• W2005338735 hasConcept C2776731609 @default.
• W2005338735 hasConcept C2778938600 @default.
• W2005338735 hasConcept C49773422 @default.
• W2005338735 hasConcept C54166955 @default.
• W2005338735 hasConcept C55493867 @default.
• W2005338735 hasConcept C80631254 @default.
• W2005338735 hasConcept C86803240 @default.
• W2005338735 hasConceptScore W2005338735C125268873 @default.
• W2005338735 hasConceptScore W2005338735C135285700 @default.
• W2005338735 hasConceptScore W2005338735C153911025 @default.
• W2005338735 hasConceptScore W2005338735C170493617 @default.
• W2005338735 hasConceptScore W2005338735C174510640 @default.
• W2005338735 hasConceptScore W2005338735C175656101 @default.

• next